Community Meeting

Triple-Negative Breast Cancer

July 10, 2012
06:00pm to 08:00pm
EDT
2012-07-10 18:00:00 2012-07-10 20:00:00 America/New_York Triple-Negative Breast Cancer 1100 Kings Highway, Cherry Hill, NJ, 08031
Cherry Hill Library
1100 Kings Highway
Cherry Hill, NJ 08031

Learn about this diagnosis of breast cancer that tests negative for the estrogen, progesterone, and HER2 receptors. Hear about the standard of care treatment options as well as pipeline research. Explore the emotional impact of living with a history of triple-negative breast cancer and hear about post-treatment lifestyle changes that can be made to reduce you risk of recurrence.

At LBBC’s July community meeting, participants learned about breast cancer that tests negative for the estrogen, progesterone and HER2 receptors. During this event, Robert Somer, MD, discussed:
  • The standard of care treatment options and pipeline research looking at the next generation of therapy
  • The emotional impact of living with a history of triple-negative breast cancer
  • Post-treatment lifestyle changes that can be made to reduce your risk of recurrence
  • Clinical trials

About Our Speaker

Robert Somer, MD, is an associate professor of medicine at the new Cooper Medical School of Rowan University in Camden, N.J. He is the director of the Cooper Cancer Center medical oncology clinical trials program; director of the Cooper Prostate Care Center at the Cooper Cancer Institute; associate director of the breast program at the Cooper Cancer Institute; and the physician QA advisor to Cooper’s cancer registry. Dr. Somer has received numerous awards during his career including the Delaware Valley Orthobiotech Fellows Research Forum in 2002 and an Amgen Fellowship in 2003. He was named a “Top Physician in America" by the Consumer’s Research Council of America in 2003 and 2004.

More In Triple-Negative